Hormone Replacement Therapy Market Size, Share & Trends | Industry Growth

 

Hormone replacement therapy (HRT) is the treatment with hormones to replace natural hormones when the body does not make enough. For instance, hormone replacement therapy may be given to thyroid patients and human growth hormone patients. In addition, HRT was prescribed commonly to menopausal women for the relief of their symptoms such as hot flushes, night sweats, sleep disturbances, psychological & genito-urinary problems (urinary frequency and vaginal dryness), and for the prevention of osteoporosis. Furthermore, the survey of 2,000 American women, aged 30 to 60, found that nearly 47% of the surveyed population have experienced the symptoms of a hormonal imbalance in 2019.

Leading players of the global Hormone Replacement Therapy Market analyzed in the research include F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Bayer AG, Abbott Laboratories, Eli Lilly and Company, Merck KGaA, Novo Nordisk A/S, and Pfizer Inc,Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.), Novartis International AG, Mylan N.V. (Viatris Inc.).

Increase in prevalence of menopausal disorder, rise in awareness regarding post-menopausal issues among women, and advent of novel hormone replacement therapies drive the growth of the global hormone replacement therapy market. However, adverse effects of the therapy and high cost of treatment restrain the market growth. On the other hand, emergence of telemedicine would offer new opportunities in the next few years.

This report on global hormone replacement therapy market is a comprehensive analysis of all the factors that are expected to influence the growth rate in near future, presents a figurative estimation of the opportunities available, and profiles some of the key players currently active to give a clear picture of the competitive landscape. The global hormone replacement therapy market can be segmented on the basis of type of therapy, route of administration, and geography. By type of therapy, the market can be divided into estrogen replacement therapy, which remains most in-demand, and growth hormone replacement therapy. By route of administration, the market can be segmented into oral, parenteral, and transdermal.